Ten ways we’ll know if we’re on track

There are 10 measures that will tell us whether we’re on track, and every year we will update our community on how we’re doing:

1. We will increase our investment in research in each of the five years of the strategy, reaching £15 million in 2027/28.
   
   
2. In 2023/24, we will identify and publish how much the UK as a whole is investing in blood cancer research, and set out a plan for how we will encourage other funders to increase their investment.
   
   
3. In 2023/24, we will establish an estimate for the number of people with blood cancer per year who die younger than they would have done if they did not have blood cancer, and set a target for reducing it.
   
   
4. In 2023/24, we will publish research setting out the main reasons some high-income countries have better blood cancer survival rates than the UK, and why some groups of people within the UK are more likely to survive than others. We will use this as a basis for a national blood cancer plan, which will set out how the UK can make the fastest progress towards the day when blood cancer is beaten.
   
   
5. Our fundraising income will significantly increase in each of the five years of the strategy, reaching £27 million in 2027/28. And our income will become more evenly distributed across fundraising streams, making us less vulnerable to unexpected drops in single income streams.
   
   
6. In each of the five years of the strategy, we will increase the proportion of people with blood cancer we are in contact with, reaching 75% of them by 2027/28.
   
   
7. In 2023/24, we will develop a plan for improving how we are meeting the needs of people from historically underserved communities. This will set out how well we are already doing, and how we plan to improve over the following four years.
   
   
8. We want the proportion of our staff recommending us as a good place to work to remain at 95% or above throughout the five years of the strategy.
   
   
9. We will benchmark the proportion of the public who have an understanding of blood cancer, and set an ambitious goal for improving this.
   
   
10. We want to become better known among people affected by blood cancer – 39% of them are currently aware of us, and we want this to increase in each of the five years of the strategy, reaching 54% by 2027/28.